Results per Page:
Your ZIP Code Can Help Inform your Survival Chances: Access Gaps in AML Treatment
From the Sorror group, Clinical Research Division
A charming model: new tool evaluates risk of transplant for older patients
Seven values are evaluated to predict outcomes
Weighing the benefits of hematopoietic stem cell transplantation for older and medically infirm patients with acute myeloid leukemia
From the Sorror Group, Clinical Research Division
Cancer clinical trials exclude too many patients: That’s changing
Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials
Improving prediction of outcomes after stem cell transplants
From the Sorror Laboratory, Clinical Research Division
New study aims to improve quality of life and survival in older, sicker bone marrow transplant patients
Large clinical trial funded by $3.5M federal research grant
Good News: Hutch investigators develop, validate novel risk-assessment model for acute myeloid leukemia
Celebrating faculty and staff achievements
Mohamed Sorror wins $951,000 from American Cancer Society
Four-year grant to Fred Hutch clinical researcher will fund study to better define therapeutic choices for older patients with newly diagnosed acute myeloid leukemia
Age alone no longer barrier to stem cell transplants for older patients
Mohamed Sorror-led study shows years play little role in patient outcomes following Center-developed 'mini-transplant'
Age no longer should be a barrier to stem cell transplantation for older patients with blood cancers
Study details outcomes of patients who received the ‘mini transplant’ developed at Fred Hutchinson Cancer Research Center